Financing (Components of Debt) (Details) € in Millions, SFr in Millions, $ in Millions, ¥ in Billions |
Jun. 26, 2026
USD ($)
|
Jun. 26, 2026
EUR (€)
|
Jun. 26, 2026
CHF (SFr)
|
Jun. 26, 2026
JPY (¥)
|
Jun. 03, 2026
CHF (SFr)
|
Apr. 23, 2026
EUR (€)
|
Mar. 18, 2026
EUR (€)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2025
EUR (€)
|
Dec. 31, 2025
CHF (SFr)
|
Dec. 31, 2025
JPY (¥)
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 26,558
|
|
|
|
|
|
|
$ 18,418
|
|
|
|
| Less: currently payable |
(1,411)
|
|
|
|
|
|
|
(2)
|
|
|
|
| Long-term debt |
25,147
|
|
|
|
|
|
|
18,416
|
|
|
|
| Euro-Denominated Commercial Paper [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Long-term debt |
4,700
|
|
|
|
|
|
|
|
|
|
|
| Other |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
1
|
|
|
|
|
|
|
1
|
|
|
|
| Senior notes | Euro-denominated commercial paper (€4.1 billion and €933 million, respectively) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 0
|
|
|
|
|
|
|
$ 1,469
|
|
|
|
| Interest rate of debt instrument |
0.20%
|
0.20%
|
0.20%
|
0.20%
|
|
|
|
0.20%
|
0.20%
|
0.20%
|
0.20%
|
| Aggregate principal amount | € |
|
€ 1,300
|
|
|
|
|
€ 1,300
|
|
€ 1,300
|
|
|
| Senior notes | 2.1% senior unsecured notes due 9/30/2026 (€800 million) (the “2026 Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 912
|
|
|
|
|
|
|
$ 940
|
|
|
|
| Interest rate of debt instrument |
2.10%
|
2.10%
|
2.10%
|
2.10%
|
|
|
|
2.10%
|
2.10%
|
2.10%
|
2.10%
|
| Aggregate principal amount | € |
|
€ 800
|
|
|
|
|
|
|
€ 800
|
|
|
| Senior notes | 0.4773% senior unsecured bonds due 4/9/2027 (CHF 250 million) (the “2027 CHF Bonds”)(f) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 308
|
|
|
|
|
|
|
$ 315
|
|
|
|
| Interest rate of debt instrument |
0.4773%
|
0.4773%
|
0.4773%
|
0.4773%
|
|
|
|
0.4773%
|
0.4773%
|
0.4773%
|
0.4773%
|
| Aggregate principal amount | SFr |
|
|
SFr 250
|
|
|
|
|
|
|
SFr 250
|
|
| Senior notes | 0.3% senior unsecured notes due 5/11/2027 (¥30.8 billion) (the “2027 Yen Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 190
|
|
|
|
|
|
|
$ 196
|
|
|
|
| Interest rate of debt instrument |
0.30%
|
0.30%
|
0.30%
|
0.30%
|
|
|
|
0.30%
|
0.30%
|
0.30%
|
0.30%
|
| Aggregate principal amount | ¥ |
|
|
|
¥ 30.8
|
|
|
|
|
|
|
¥ 30.8
|
| Senior notes | 1.2% senior unsecured notes due 6/30/2027 (€600 million) (the “2027 Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 683
|
|
|
|
|
|
|
$ 704
|
|
|
|
| Interest rate of debt instrument |
1.20%
|
1.20%
|
1.20%
|
1.20%
|
|
|
|
1.20%
|
1.20%
|
1.20%
|
1.20%
|
| Aggregate principal amount | € |
|
€ 600
|
|
|
|
|
|
|
€ 600
|
|
|
| Senior notes | 0.45% senior unsecured notes due 3/18/2028 (€1.3 billion) (the “2028 Biopharma Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 1,421
|
|
|
|
|
|
|
$ 1,466
|
|
|
|
| Interest rate of debt instrument |
0.45%
|
0.45%
|
0.45%
|
0.45%
|
|
|
|
0.45%
|
0.45%
|
0.45%
|
0.45%
|
| Aggregate principal amount | € |
|
€ 1,300
|
|
|
|
|
|
|
€ 1,300
|
|
|
| Senior notes | Floating rate senior unsecured notes due 4/29/2028 (€500 million) (the “2028 Floating Rate Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 567
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Aggregate principal amount | € |
|
€ 500
|
|
|
|
€ 500
|
|
|
€ 500
|
|
|
| Senior notes | 0.8875% senior unsecured bonds due 10/10/2029 (CHF 325 million) (the “2029 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 400
|
|
|
|
|
|
|
$ 409
|
|
|
|
| Interest rate of debt instrument |
0.8875%
|
0.8875%
|
0.8875%
|
0.8875%
|
|
|
|
0.8875%
|
0.8875%
|
0.8875%
|
0.8875%
|
| Aggregate principal amount | SFr |
|
|
SFr 325
|
|
|
|
|
|
|
SFr 325
|
|
| Senior notes | 2.6% senior unsecured notes due 11/15/2029 ($800 million) (the “2029 Biopharma Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 798
|
|
|
|
|
|
|
$ 798
|
|
|
|
| Interest rate of debt instrument |
2.60%
|
2.60%
|
2.60%
|
2.60%
|
|
|
|
2.60%
|
2.60%
|
2.60%
|
2.60%
|
| Aggregate principal amount |
$ 800
|
|
|
|
|
|
|
$ 800
|
|
|
|
| Senior notes | 2.5% senior unsecured notes due 3/30/2030 (€800 million) (the “2030 Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 911
|
|
|
|
|
|
|
$ 940
|
|
|
|
| Interest rate of debt instrument |
2.50%
|
2.50%
|
2.50%
|
2.50%
|
|
|
|
2.50%
|
2.50%
|
2.50%
|
2.50%
|
| Aggregate principal amount | € |
|
€ 800
|
|
|
|
|
|
|
€ 800
|
|
|
| Senior notes | 3.250% senior unsecured notes due 4/29/2030 (€750 million) (the “2030 Euronotes II”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 849
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
3.25%
|
3.25%
|
3.25%
|
3.25%
|
|
3.25%
|
|
3.25%
|
3.25%
|
3.25%
|
3.25%
|
| Aggregate principal amount | € |
|
€ 750
|
|
|
|
€ 750
|
|
|
€ 750
|
|
|
| Senior notes | 1.65% senior unsecured bonds due 6/3/2031 (CHF 120 million) (the “2031 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 147
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
1.65%
|
1.65%
|
1.65%
|
1.65%
|
1.65%
|
|
|
1.65%
|
1.65%
|
1.65%
|
1.65%
|
| Aggregate principal amount | SFr |
|
|
SFr 120
|
|
SFr 120
|
|
|
|
|
SFr 120
|
|
| Senior notes | 0.75% senior unsecured notes due 9/18/2031 (€1.8 billion) (the “2031 Biopharma Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 1,987
|
|
|
|
|
|
|
$ 2,050
|
|
|
|
| Interest rate of debt instrument |
0.75%
|
0.75%
|
0.75%
|
0.75%
|
|
|
|
0.75%
|
0.75%
|
0.75%
|
0.75%
|
| Aggregate principal amount | € |
|
€ 1,800
|
|
|
|
|
|
|
€ 1,800
|
|
|
| Senior notes | 0.65% senior unsecured notes due 5/11/2032 (¥53.2 billion) (the “2032 Yen Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 328
|
|
|
|
|
|
|
$ 339
|
|
|
|
| Interest rate of debt instrument |
0.65%
|
0.65%
|
0.65%
|
0.65%
|
|
|
|
0.65%
|
0.65%
|
0.65%
|
0.65%
|
| Aggregate principal amount | ¥ |
|
|
|
¥ 53.2
|
|
|
|
|
|
|
¥ 53.2
|
| Senior notes | 1.88% senior unsecured bonds due 6/3/2033 (CHF 137 million) (the “2033 CHF Bonds II”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 169
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
1.88%
|
1.88%
|
1.88%
|
1.88%
|
1.88%
|
|
|
1.88%
|
1.88%
|
1.88%
|
1.88%
|
| Aggregate principal amount | SFr |
|
|
SFr 137
|
|
SFr 137
|
|
|
|
|
SFr 137
|
|
| Senior notes | 1.265% senior unsecured bonds due 10/10/2033 (CHF 325 million) (the “2033 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 400
|
|
|
|
|
|
|
$ 408
|
|
|
|
| Interest rate of debt instrument |
1.265%
|
1.265%
|
1.265%
|
1.265%
|
|
|
|
1.265%
|
1.265%
|
1.265%
|
1.265%
|
| Aggregate principal amount | SFr |
|
|
SFr 325
|
|
|
|
|
|
|
SFr 325
|
|
| Senior notes | 3.625% senior unsecured notes due 4/29/2034 (€750 million) (the “2034 Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 848
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
3.625%
|
3.625%
|
3.625%
|
3.625%
|
|
3.625%
|
|
3.625%
|
3.625%
|
3.625%
|
3.625%
|
| Aggregate principal amount | € |
|
€ 750
|
|
|
|
€ 750
|
|
|
€ 750
|
|
|
| Senior notes | 2.10% senior unsecured bonds due 6/3/2036 (CHF 221 million) (the 2036 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 272
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
2.10%
|
2.10%
|
2.10%
|
2.10%
|
2.10%
|
|
|
2.10%
|
2.10%
|
2.10%
|
2.10%
|
| Aggregate principal amount | SFr |
|
|
SFr 221
|
|
SFr 221
|
|
|
|
|
SFr 221
|
|
| Senior notes | 1.6249% senior unsecured bonds due 10/9/2037 (CHF 225 million) (the “2037 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 276
|
|
|
|
|
|
|
$ 282
|
|
|
|
| Interest rate of debt instrument |
1.6249%
|
1.6249%
|
1.6249%
|
1.6249%
|
|
|
|
1.6249%
|
1.6249%
|
1.6249%
|
1.6249%
|
| Aggregate principal amount | SFr |
|
|
SFr 225
|
|
|
|
|
|
|
SFr 225
|
|
| Senior notes | 4.000% senior unsecured notes due 4/29/2038 (€1.0 billion) the (“2038 Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 1,130
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
4.00%
|
4.00%
|
4.00%
|
4.00%
|
|
4.00%
|
|
4.00%
|
4.00%
|
4.00%
|
4.00%
|
| Aggregate principal amount | € |
|
€ 1,000
|
|
|
|
€ 1,000
|
|
|
€ 1,000
|
|
|
| Senior notes | 2.25% senior unsecured bonds due 6/3/2038 (CHF 373 million) (the “2038 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 457
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
2.25%
|
2.25%
|
2.25%
|
2.25%
|
2.25%
|
|
|
2.25%
|
2.25%
|
2.25%
|
2.25%
|
| Aggregate principal amount | SFr |
|
|
SFr 373
|
|
SFr 373
|
|
|
|
|
SFr 373
|
|
| Senior notes | 1.35% senior unsecured notes due 9/18/2039 (€1.3 billion) (the “2039 Biopharma Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 1,410
|
|
|
|
|
|
|
$ 1,456
|
|
|
|
| Interest rate of debt instrument |
1.35%
|
1.35%
|
1.35%
|
1.35%
|
|
|
|
1.35%
|
1.35%
|
1.35%
|
1.35%
|
| Aggregate principal amount | € |
|
€ 1,300
|
|
|
|
|
|
|
€ 1,300
|
|
|
| Senior notes | 3.25% senior unsecured notes due 11/15/2039 ($900 million) (the “2039 Biopharma Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 892
|
|
|
|
|
|
|
$ 892
|
|
|
|
| Interest rate of debt instrument |
3.25%
|
3.25%
|
3.25%
|
3.25%
|
|
|
|
3.25%
|
3.25%
|
3.25%
|
3.25%
|
| Aggregate principal amount |
$ 900
|
|
|
|
|
|
|
$ 900
|
|
|
|
| Senior notes | 2.38% senior unsecured bonds due 6/3/2041 (CHF 648 million) (the “2041 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 795
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
2.38%
|
2.38%
|
2.38%
|
2.38%
|
2.38%
|
|
|
2.38%
|
2.38%
|
2.38%
|
2.38%
|
| Aggregate principal amount | SFr |
|
|
SFr 648
|
|
SFr 648
|
|
|
|
|
SFr 648
|
|
| Senior notes | 2.38% senior unsecured bonds due 6/3/2041 (CHF 648 million) (the “2041 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 500
|
|
|
|
|
|
|
$ 500
|
|
|
|
| Interest rate of debt instrument |
4.375%
|
4.375%
|
4.375%
|
4.375%
|
|
|
|
4.375%
|
4.375%
|
4.375%
|
4.375%
|
| Aggregate principal amount |
$ 500
|
|
|
|
|
|
|
$ 500
|
|
|
|
| Senior notes | 2.38% senior unsecured bonds due 6/3/2041 (CHF 648 million) (the “2041 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 153
|
|
|
|
|
|
|
$ 157
|
|
|
|
| Interest rate of debt instrument |
1.94%
|
1.94%
|
1.94%
|
1.94%
|
|
|
|
1.94%
|
1.94%
|
1.94%
|
1.94%
|
| Aggregate principal amount | SFr |
|
|
SFr 125
|
|
|
|
|
|
|
SFr 125
|
|
| Senior notes | 2.51% senior unsecured bonds due 6/3/2046 (CHF 502 million) (the 2046 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 616
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
2.51%
|
2.51%
|
2.51%
|
2.51%
|
2.51%
|
|
|
2.51%
|
2.51%
|
2.51%
|
2.51%
|
| Aggregate principal amount | SFr |
|
|
SFr 502
|
|
SFr 502
|
|
|
|
|
SFr 502
|
|
| Senior notes | 1.8% senior unsecured notes due 9/18/2049 (€750 million) (the “2049 Biopharma Euronotes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 845
|
|
|
|
|
|
|
$ 873
|
|
|
|
| Interest rate of debt instrument |
1.80%
|
1.80%
|
1.80%
|
1.80%
|
|
|
|
1.80%
|
1.80%
|
1.80%
|
1.80%
|
| Aggregate principal amount | € |
|
€ 750
|
|
|
|
|
|
|
€ 750
|
|
|
| Senior notes | 3.4% senior unsecured notes due 11/15/2049 ($900 million) (the “2049 Biopharma Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 891
|
|
|
|
|
|
|
$ 891
|
|
|
|
| Interest rate of debt instrument |
3.40%
|
3.40%
|
3.40%
|
3.40%
|
|
|
|
3.40%
|
3.40%
|
3.40%
|
3.40%
|
| Aggregate principal amount |
$ 900
|
|
|
|
|
|
|
$ 900
|
|
|
|
| Senior notes | 2.6% senior unsecured notes due 10/01/2050 ($1.0 billion) (the “2050 U.S. Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 983
|
|
|
|
|
|
|
$ 983
|
|
|
|
| Interest rate of debt instrument |
2.60%
|
2.60%
|
2.60%
|
2.60%
|
|
|
|
2.60%
|
2.60%
|
2.60%
|
2.60%
|
| Aggregate principal amount |
$ 1,000
|
|
|
|
|
|
|
$ 1,000
|
|
|
|
| Senior notes | 2.8% senior unsecured notes due 12/10/2051 ($1.0 billion) (the “2051 U.S. Notes”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 986
|
|
|
|
|
|
|
$ 985
|
|
|
|
| Interest rate of debt instrument |
2.80%
|
2.80%
|
2.80%
|
2.80%
|
|
|
|
2.80%
|
2.80%
|
2.80%
|
2.80%
|
| Aggregate principal amount |
$ 1,000
|
|
|
|
|
|
|
$ 1,000
|
|
|
|
| Senior notes | 2.50% senior unsecured bonds due 6/3/2056 (CHF 382 million) (the 2056 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 469
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Interest rate of debt instrument |
2.50%
|
2.50%
|
2.50%
|
2.50%
|
2.50%
|
|
|
2.50%
|
2.50%
|
2.50%
|
2.50%
|
| Aggregate principal amount | SFr |
|
|
SFr 382
|
|
SFr 382
|
|
|
|
|
SFr 382
|
|
| Bonds | 1.125% senior unsecured bonds due 12/08/2028 (CHF 210 million) (the “2028 CHF Bonds”) |
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Subtotal |
$ 261
|
|
|
|
|
|
|
$ 267
|
|
|
|
| Interest rate of debt instrument |
1.125%
|
1.125%
|
1.125%
|
1.125%
|
|
|
|
1.125%
|
1.125%
|
1.125%
|
1.125%
|
| Aggregate principal amount | SFr |
|
|
SFr 210
|
|
|
|
|
|
|
SFr 210
|
|